Inogen, Inc. (INGN)
NASDAQ: INGN · Real-Time Price · USD
7.02
-0.17 (-2.36%)
At close: May 8, 2026, 4:00 PM EDT
6.98
-0.04 (-0.57%)
Pre-market: May 11, 2026, 7:14 AM EDT
Inogen Revenue
Inogen had revenue of $85.11M in the quarter ending March 31, 2026, with 3.44% growth. This brings the company's revenue in the last twelve months to $351.50M, up 3.39% year-over-year. In the year 2025, Inogen had annual revenue of $348.67M with 3.86% growth.
Revenue (ttm)
$351.50M
Revenue Growth
+3.39%
P/S Ratio
0.55
Revenue / Employee
$466,795
Employees
753
Market Cap
191.82M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 348.67M | 12.96M | 3.86% |
| Dec 31, 2024 | 335.71M | 20.05M | 6.35% |
| Dec 31, 2023 | 315.66M | -61.58M | -16.32% |
| Dec 31, 2022 | 377.24M | 19.24M | 5.37% |
| Dec 31, 2021 | 358.00M | 49.52M | 16.05% |
| Dec 31, 2020 | 308.49M | -53.46M | -14.77% |
| Dec 31, 2019 | 361.94M | 3.83M | 1.07% |
| Dec 31, 2018 | 358.11M | 108.67M | 43.57% |
| Dec 31, 2017 | 249.44M | 46.61M | 22.98% |
| Dec 31, 2016 | 202.83M | 43.82M | 27.56% |
| Dec 31, 2015 | 159.01M | 46.47M | 41.29% |
| Dec 31, 2014 | 112.54M | 37.09M | 49.17% |
| Dec 31, 2013 | 75.44M | 26.87M | 55.31% |
| Dec 31, 2012 | 48.58M | 17.94M | 58.57% |
| Dec 31, 2011 | 30.63M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| InfuSystem Holdings | 142.40M |
| RxSight | 127.48M |
| Owlet | 105.71M |
| Electromed | 68.86M |
| CVRx, Inc. | 56.65M |
| Apyx Medical | 52.84M |
| Senseonics Holdings | 35.26M |
| Profound Medical | 16.10M |
INGN News
- 3 days ago - Inogen reports Q1 EPS (30c), one estimate (21c) - TheFly
- 3 days ago - Inogen Earnings Call Transcript: Q1 2026 - Transcripts
- 3 days ago - Inogen Announces First Quarter 2026 Financial Results - Business Wire
- 17 days ago - Inogen to Report First Quarter 2026 Financial Results on May 7, 2026 - Business Wire
- 26 days ago - Inogen Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 4 weeks ago - Inogen initiated with a Buy at Freedom Broker - TheFly
- 4 weeks ago - Inogen Announces the Appointment of Vafa Jamali to Board of Directors - Business Wire
- 5 weeks ago - Inogen Announces Participation in the 25th Annual Needham Virtual Healthcare Conference - Business Wire